237 related articles for article (PubMed ID: 34066099)
1. Cell-Penetrating Peptides-Based Liposomal Delivery System Enhanced Immunogenicity of Peptide-Based Vaccine against Group A Streptococcus.
Yang J; Firdaus F; Azuar A; Khalil ZG; Marasini N; Capon RJ; Hussein WM; Toth I; Skwarczynski M
Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34066099
[TBL] [Abstract][Full Text] [Related]
2. Activity Relationship of Poly(ethylenimine)-Based Liposomes as Group A
Jin S; Zhang J; Nahar UJ; Huang W; Alharbi NA; Shalash AO; Koirala P; Yang J; Kiong JJE; Khalil ZG; Capon RJ; Stephenson RJ; Skwarczynski M; Toth I; Hussein WM
ACS Infect Dis; 2023 Aug; 9(8):1570-1581. PubMed ID: 37489053
[TBL] [Abstract][Full Text] [Related]
3. The Development of Surface-Modified Liposomes as an Intranasal Delivery System for Group A Streptococcus Vaccines.
Yang J; Boer JC; Khongkow M; Phunpee S; Khalil ZG; Bashiri S; Deceneux C; Goodchild G; Hussein WM; Capon RJ; Ruktanonchai U; Plebanski M; Toth I; Skwarczynski M
Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851183
[TBL] [Abstract][Full Text] [Related]
4. Polyethylenimine: An Intranasal Adjuvant for Liposomal Peptide-Based Subunit Vaccine against Group A
Dai CC; Yang J; Hussein WM; Zhao L; Wang X; Khalil ZG; Capon RJ; Toth I; Stephenson RJ
ACS Infect Dis; 2020 Sep; 6(9):2502-2512. PubMed ID: 32786276
[TBL] [Abstract][Full Text] [Related]
5. Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A Streptococcus.
Azuar A; Madge HYR; Boer JC; Gonzalez Cruz JL; Wang J; Khalil ZG; Deceneux C; Goodchild G; Yang J; Koirala P; Hussein WM; Capon RJ; Plebanski M; Toth I; Skwarczynski M
Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 36016100
[TBL] [Abstract][Full Text] [Related]
6. Development of Polyelectrolyte Complexes for the Delivery of Peptide-Based Subunit Vaccines against Group A
Zhao L; Jin W; Cruz JG; Marasini N; Khalil ZG; Capon RJ; Hussein WM; Skwarczynski M; Toth I
Nanomaterials (Basel); 2020 Apr; 10(5):. PubMed ID: 32357402
[TBL] [Abstract][Full Text] [Related]
7. Liposome-based intranasal delivery of lipopeptide vaccine candidates against group A streptococcus.
Ghaffar KA; Marasini N; Giddam AK; Batzloff MR; Good MF; Skwarczynski M; Toth I
Acta Biomater; 2016 Sep; 41():161-8. PubMed ID: 27063491
[TBL] [Abstract][Full Text] [Related]
8. Development of Multilayer Nanoparticles for the Delivery of Peptide-Based Subunit Vaccine against Group A
Kiong J; Nahar UJ; Jin S; Shalash AO; Zhang J; Koirala P; Khalil ZG; Capon RJ; Skwarczynski M; Toth I; Hussein WM
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297584
[TBL] [Abstract][Full Text] [Related]
9. Lipid core peptide/poly(lactic-co-glycolic acid) as a highly potent intranasal vaccine delivery system against Group A streptococcus.
Marasini N; Khalil ZG; Giddam AK; Ghaffar KA; Hussein WM; Capon RJ; Batzloff MR; Good MF; Skwarczynski M; Toth I
Int J Pharm; 2016 Nov; 513(1-2):410-420. PubMed ID: 27659862
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol as an inbuilt immunoadjuvant for a lipopeptide vaccine against group A Streptococcus infection.
Alharbi N; Shalash AO; Koirala P; Boer JC; Hussein WM; Khalil ZG; Capon RJ; Plebanski M; Toth I; Skwarczynski M
J Colloid Interface Sci; 2024 Jun; 663():43-52. PubMed ID: 38387185
[TBL] [Abstract][Full Text] [Related]
11. Self-assembled monovalent lipidated mannose ligand as a standalone nanoadjuvant.
Nahar UJ; Wang J; Shalash AO; Lu L; Islam MT; Alharbi N; Koirala P; Khalil ZG; Capon RJ; Hussein WM; Toth I; Skwarczynski M
Vaccine; 2024 Jun; ():. PubMed ID: 38897890
[TBL] [Abstract][Full Text] [Related]
12. A dual-adjuvanting strategy for peptide-based subunit vaccines against group A Streptococcus: Lipidation and polyelectrolyte complexes.
Zhao L; Yang J; Nahar UJ; Khalil ZG; Capon RJ; Hussein WM; Skwarczynski M; Toth I
Bioorg Med Chem; 2020 Dec; 28(24):115823. PubMed ID: 33120079
[TBL] [Abstract][Full Text] [Related]
13. Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcus.
Nevagi RJ; Khalil ZG; Hussein WM; Powell J; Batzloff MR; Capon RJ; Good MF; Skwarczynski M; Toth I
Acta Biomater; 2018 Oct; 80():278-287. PubMed ID: 30266637
[TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity.
Backlund CM; Holden RL; Moynihan KD; Garafola D; Farquhar C; Mehta NK; Maiorino L; Pham S; Iorgulescu JB; Reardon DA; Wu CJ; Pentelute BL; Irvine DJ
Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2204078119. PubMed ID: 35914154
[TBL] [Abstract][Full Text] [Related]
15. Dual-Modified Liposome for Targeted and Enhanced Gene Delivery into Mice Brain.
Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
J Pharmacol Exp Ther; 2020 Sep; 374(3):354-365. PubMed ID: 32561686
[TBL] [Abstract][Full Text] [Related]
16. Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct.
Olive C; Batzloff M; Horváth A; Clair T; Yarwood P; Toth I; Good MF
Indian J Med Res; 2004 May; 119 Suppl():88-94. PubMed ID: 15232170
[TBL] [Abstract][Full Text] [Related]
17. Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens.
Olive C; Batzloff M; Horváth A; Clair T; Yarwood P; Toth I; Good MF
Infect Immun; 2003 May; 71(5):2373-83. PubMed ID: 12704107
[TBL] [Abstract][Full Text] [Related]
18. Highly Immunogenic Trimethyl Chitosan-based Delivery System for Intranasal Lipopeptide Vaccines against Group A Streptococcus.
Marasini N; Ghaffar KA; Giddam AK; Batzloff MR; Good MF; Skwarczynski M; Toth I
Curr Drug Deliv; 2017; 14(5):701-708. PubMed ID: 27440071
[TBL] [Abstract][Full Text] [Related]
19. Cell-Penetrating Peptides as a Potential Drug Delivery System for Effective Treatment of Diabetes.
Korivi M; Huang YW; Liu BR
Curr Pharm Des; 2021; 27(6):816-825. PubMed ID: 33076803
[TBL] [Abstract][Full Text] [Related]
20. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.
Olive C; Sun HK; Ho MF; Dyer J; Horváth A; Toth I; Good MF
J Infect Dis; 2006 Aug; 194(3):316-24. PubMed ID: 16826479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
